Press "Enter" to skip to content

New patent for Axsome drug AUVELITY

0
Copyright © DrugPatentWatch. Originally published at New patent for Axsome drug AUVELITY

Annual Drug Patent Expirations for AUVELITY
Annual Drug Patent Expirations for AUVELITY

Auvelity is a drug marketed by Axsome and is included in one NDA. It is available from one supplier. There are ninety-six patents protecting this drug.

This drug has one hundred and thirty-three patent family members in thirty countries.

The generic ingredient in AUVELITY is bupropion hydrochloride; dextromethorphan hydrobromide. One supplier is listed for this compound. Additional details are available on the bupropion hydrochloride; dextromethorphan hydrobromide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Axsome drug AUVELITY
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions